© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
In science classes, most people remember the bold colors from test tubes or the spidery shapes of glassware on the counter. Potassium antimonyl tartrate monohydrate—an old mouthful of a chemical—played out its role in medicine and research before modern drugs even entered the picture. For centuries, this compound—sometimes called tartar emetic—worked its way through the pages of chemistry books and hospital records. Chemists isolated it by accident more than once, drawn by its glittery white crystals and the odd way it helped control vomiting. Doctors once reached for it to treat parasites like schistosomiasis, a practice that might seem dangerous today but spoke to their drive to save lives using whatever tools they had. Its history, sometimes tangled up in hardship and hope, stands as a reminder of how far medicine’s come, and how trial, error, and keen observation shaped chemical knowledge long before computer models or mass spectrometers showed up.
People who love chemistry say this compound makes for wonderful teaching material. Its structure twists together potassium, antimony, tartaric acid, and a single water molecule. It doesn’t blend into the crowd—these white, needle-like crystals dissolve in water, which helps explain why it entered the world of medicine despite its risks. The scientific formula, K2Sb2(C4H2O6)2·H2O, tells a story by itself, but the real tale comes when one looks at its properties and behavior, which run toward the unpredictable, especially in the hands of someone who isn’t careful. It doesn’t melt easily, but triggers uncomfortable reactions in the human body fast enough that no one would forget handling it without gloves. Given enough heat, it breaks down to release antimony oxides and tartronic acid derivatives—a tricky combination for both the body and the lab. Many researchers, myself included, have heard stories of old chemists using it as a benchmark in studying complex coordination chemicals.
Ask any veteran chemist and they’ll rattle off a list of names for this compound. Potassium antimonyl tartrate monohydrate, tartar emetic, emetic tartar, potassium antimony tartrate—all these labels mark the same substance. This isn’t just a quirk. It speaks to the compound’s journey through medicine, pharmacy, and chemical supply houses. Old medical books called it “tartar emetic” as it pushed up the urge to vomit, a side effect that drove both its value and its danger. The regulatory world, wary of poisoning, later demanded labeling that spelled out “antimony,” hammering home its risks. As a scientist, these layers of naming tell me how culture and safety standards press chemicals into new boxes as our understanding grows.
Potassium antimonyl tartrate monohydrate doesn’t form in some bubbling volcanic spring. Making it generally kicks off by reacting antimony trioxide with potassium bitartrate in aqueous solution, followed by careful filtration and slow cooling to coax out the crystals. Tweaking this basic reaction by introducing heat or different acids can throw off the crystal form, change solubility, or mess with its stability. Modifications over the years have chased higher purity or shifted ratios to reduce the amount of free antimony, since that’s the part that gives regulators headaches. In teaching labs, handling the stuff drives home the message—mixing things right and following recipes matters, but understanding the hazards matters more.
I remember the stern warnings from professors when antimony compounds appeared on the docket. This one stands out as especially toxic—not something anyone wants drifting into a sandwich or coffee cup by mistake. Exposure causes vomiting, liver and heart problems, even fatality in severe cases. Regulatory agencies and chemical suppliers flag it with strong labeling, limits on how much anyone can buy, and requirements for gloves, masks, and fume hoods. Over time, lab practices grew up to meet its risks, from closed systems in chemical plants to mandatory training in academic settings. What strikes me is how the rules written around it grew stricter as cases of accidental poisoning came to light, forcing both manufacturers and individual researchers to treat the compound with the respect it demands.
Potassium antimonyl tartrate monohydrate found its strange fame in medicine. For generations, doctors fought parasites—especially schistosomiasis and leishmaniasis—using the compound’s toxic touch to knock out stubborn infections. Some used it to induce vomiting, a method most would call dangerous now, but one that seemed like a godsend in times before antibiotics and safer drugs. The story doesn’t stop there, though. Chemists often used it to study the properties of antimony complex ions, and as a benchmark in the quantification of reducing sugars. Textile workers and tanners once used it to finish products, while analysts employed it to test for reducing sugars. Now most industries step back, only using it in specialty diagnostics or as a teaching tool for chemistry students. From my view, this pattern shows how progress nudges dangerous compounds aside, replacing them with safer, targeted alternatives, but never erasing the history that earned them their spot in textbooks.
The story of potassium antimonyl tartrate monohydrate highlights the close dance between biochemical promise and gritty reality. Early research drowned out the toll it took on human health, focusing instead on its effectiveness against tricky diseases. Once scientists figured out how antimony compounds distributed themselves in the body and stayed there for stubbornly long stretches, the dangers stared everyone in the face. Modern studies dig deeper, documenting chronic exposure risks—heart dysfunction, liver failure, skin damage—and the wider environmental footprint of careless disposal. Regulatory changes followed suit, with labs and hospitals required to lock away their stocks and use strict protocols for waste. In experience, watching these safety shifts teaches more about scientific humility than textbook chemical equations ever did.
Few chemicals stick around in the spotlight after doctors and chemists move on. Potassium antimonyl tartrate monohydrate seems destined for the back shelf, raised up not as a star player in modern medicine but as a lesson in scientific risk—and the creative drive to solve problems with what’s on hand. Current research circles back to new analytical uses and explores how to neutralize its environmental effects. Some labs, especially in places where safer alternatives are tough to find, still turn to it in emergencies, balancing its hazards against the greater risk of untreated disease. Looking ahead, the focus shifts toward managing leftover contamination and designing future compounds that keep their benefits without dealing the same harm. There’s something to learn from the arc of this chemical’s history: every bit of scientific growth comes with a look back at earlier methods, a deepened respect for safety, and a promise to do better with both knowledge and care.
Most of us don’t come across potassium antimonyl tartrate monohydrate in daily life. The long name sounds straight from a chemistry textbook, yet this compound has a history that might surprise some people. Years ago, potassium antimonyl tartrate—sometimes called tartar emetic—showed up on pharmacy shelves and in hospitals. Its main use? Treating parasitic diseases, especially schistosomiasis and leishmaniasis.
Parasitic diseases threaten millions of people, especially where healthcare access faces big gaps. Back in the day, doctors saw only a few options for treating these infections. Potassium antimonyl tartrate stepped in as a treatment. Injections would break up parasites in the body, giving patients a shot at recovery. Health workers—often in remote places—relied on this compound for people with few other choices.
Potassium antimonyl tartrate can work against parasites, but the story’s full of risk. Researchers and doctors have flagged some serious side effects. We're talking muscle pain, damage to the liver, heart problems, and even death in extreme cases. I think about old hospital stories, where supplies came with warning labels and extra paperwork. Nurses had to double-check everything, watching patients for dangerous reactions.
These real risks led the medical world to look for safer options. Most modern guidelines suggest avoiding potassium antimonyl tartrate unless there's no alternative. The development of better drugs nudged this compound out of the spotlight in many countries. For example, antimonial drugs used in the past have gradually faded as miltefosine or amphotericin B stepped in with fewer dangerous side effects, according to the World Health Organization.
While medicine might be moving on, potassium antimonyl tartrate hasn’t disappeared completely. It plays a role in analytical chemistry. In labs, scientists use it to measure blood glucose or test for certain metals. For me, having worked in a university lab, handling any chemical like this demands caution. We always checked protocols, stored materials securely, and cleaned up after ourselves. One slip could lead to exposure, affecting not just you but everyone in the lab.
Companies storing this compound follow strict rules set by regulators, such as the U.S. Occupational Safety and Health Administration (OSHA). These standards keep workers safe and prevent environmental harm. Scientists still value potassium antimonyl tartrate for its reliability in some tests, but there's no excuse for skipping safety steps.
Medical progress often means replacing old drugs with safer, more effective ones. The story of potassium antimonyl tartrate shows both the hidden dangers and the value of new discoveries. For regions where modern treatments remain out of reach, organizations like Médecins Sans Frontières keep pushing for affordable access to better medications. It's a reminder that supporting research matters—not just in big cities, but everywhere.
For anyone still working with potassium antimonyl tartrate, vigilance is non-negotiable. Respect for these compounds ensures safety for staff, patients, and communities. By learning from the past, and staying updated on science, we protect health and open doors to safer treatments down the line.
Potassium antimonyl tartrate monohydrate shows up in chemistry labs with the formula K2Sb2(C4H2O6)2·H2O. It grabs attention because the formula packs together potassium, antimony, and tartrate ligands with a single water molecule clinging to the structure. Spotting this compound in a reagent bottle used to fill me with curiosity; it’s not the sort of thing most people run into, but there’s a deep story here, especially for anyone studying metals, history, or medicine.
History books point to potassium antimonyl tartrate by its old name, tartar emetic. Up to the middle of the twentieth century, physicians depended on it to treat a range of illnesses, such as schistosomiasis and leishmaniasis. Its formula is more than a mix of letters and numbers—every atom fits into a certain place, each part contributing to the compound’s activity and behavior both in water and in the body. Potassium and antimony balance out the charges, while the tartrate provides a system to hold metal atoms in check so they do not react too quickly or break apart.
Researchers learned quickly that too much exposure leads to strong side effects. Nausea hits hard, sometimes followed by more severe trouble for the liver and heart. Reading old treatment records, it becomes painfully clear that chemistry wasn’t just an academic exercise—real patients depended on accuracy and consistency. That’s why a precise formula was always vital. No room for guesswork exists when human lives hang in the balance.
During my own work in a small college chemistry lab, potassium antimonyl tartrate often played a role as a standard in titration or as a reactant with hydrogen sulfide in classic qualitative experiments. Lab safety protocols never let anyone treat it lightly—safe practices meant life, not just compliance. Even years after its big days in medicine, the compound still surfaces in analytical chemistry for detecting tiny amounts of certain metals or as a catalyst in chemical synthesis.
The water molecule attached to the structure might seem a minor detail, but it makes a difference in the properties. Heating the monohydrate drives off that water, adjusting the weight and maybe the behavior in a reaction. Weighing solids in the lab, this detail always kept me alert, double-checking that the right version went into the flask.
Medical science moves on, often trading old remedies for safer, more effective ones. The story of potassium antimonyl tartrate monohydrate stands out as a warning and a lesson. Modern drugs for parasitic infections do the job with less risk. Few non-chemists run into this compound today, and that’s a sign of progress in patient safety.
Focusing on chemical literacy helps health professionals and scientists make decisions with confidence. Getting the formula exactly right shuts the door on expensive mistakes. In a world with new substances coming to market every week, that lesson never goes out of date.
Potassium antimonyl tartrate monohydrate, with its formula K2Sb2(C4H2O6)2·H2O, reminds us how ideas in chemistry, caution, and real-world use walk together, every step grounded in clear, accurate science.
Potassium antimonyl tartrate monohydrate has an odd spot in the story of medicine and industry. The name rarely comes up in conversation, but this compound has been around for centuries. Known for years as tartar emetic, early doctors once used it to trigger vomiting after poisonings or even to battle diseases. Old strategies like that never last, especially when people start to notice the price paid in side effects and fatalities. That fact says more than all the clinical trials in the world: this isn’t something for light handling.
Personal stories about this chemical have a common thread—danger at low doses. The World Health Organization classifies compounds containing antimony as toxic, and the CDC calls potassium antimonyl tartrate “highly hazardous.” Accidentally swallowing just 30 milligrams can bring on nausea, vomiting, and serious heart rhythm changes. Dose goes up, chance of survival shrinks. Even skin contact or breathing dust can irritate and inflame the body. You won’t see this stuff lying around a modern science classroom for a reason.
Like many heavy metals, antimony has a knack for sneaking its way deep into organs. Animal studies show the compound builds up in the liver, lungs, and kidneys, causing cellular damage. Poisonings haven’t vanished, especially in places where old pest controls and traditional medicines still include antimony in their recipes. It became notorious during the 1800s for killing patients instead of curing them. That history alone should raise alarms, but the link to cancer risk and reproductive problems keeps the red flag waving tightly in 2024.
Jobs in chemical manufacturing, glassmaking, and even ceramics sometimes bring staff face-to-face with sources of antimony compounds. Health agencies demand protective gear and strict rules for a reason. You can’t see the hazard, but you know it’s lurking in the powdery dust and splashy solutions. Regulations in countries like the United States and members of the European Union treat exposure to potassium antimonyl tartrate as an urgent workplace risk. The facts show this isn’t an overreaction. OSHA limits occupational exposure levels to tiny concentrations—just 0.5 mg/m³ of antimony compounds in air.
Sadly, not every country holds up those standards, and informal or illegal industries sometimes skip the safety steps. Experience in global health shows that workers in underregulated settings are the most likely to suffer. Poisonings stack up in communities where laws don’t get enforced or public health messaging runs thin.
Eliminating unnecessary use stands as the first line of defense. Doctors and patients left potassium antimonyl tartrate behind decades ago in favor of safer treatments. Industry substitutes have reduced the need for it in glass production and pesticides. But in labs and factories handling this chemical, the safest practices get taught early: always use gloves, full face protection, and top-tier ventilation systems. Training turns into habit, and habit protects lives.
Environmental groups and public health advocates push for both tighter regulation and broader education, stressing that workers must know what’s in their materials. More could be done to restrict sale and use in high-risk environments, and routine monitoring keeps accidental exposure in check. Putting health first means learning from the past and refusing to ignore the well-documented hazards packed into this forgotten compound.
Potassium antimonyl tartrate monohydrate sits on the list of chemicals that many folks in labs take for granted, especially in places focused on research or testing. I’ve seen how one misplaced container, sealed wrong or left near a hot vent, can spark hours of needless panic and cleanup. People trust that labels and protocols do most of the heavy lifting, yet mishandling risks never go away just because a policy sits on a shelf.
This compound, used in some diagnostic microbiology and classical chemistry experiments, brings with it real hazards. It doesn’t just irritate skin and eyes—breathing in its dust can cause lasting harm to your lungs and nervous system. That changes the conversation from “keep it away from sunlight” to a demand for reliable, practiced care every day. Any lab worker who’s pulled powder from a crusty bottle knows the tension of wondering how well it’s held up. There’s a lot riding on the choices made before anyone even pops the lid.
One lesson sticks with me: never trust a forgotten corner or an old label. Chemicals like potassium antimonyl tartrate monohydrate need a clean, dry, and cool home. Moisture in the air creeps into bags and jars, changing what’s inside and sometimes causing dangerous caking or clumping, which nobody wants to deal with. Vents and radiators don’t belong nearby, and open shelving at head height raises the stakes if a jar ever slips.
Keep the stuff in a spot with controlled temperature, away from sunlight and heat sources. I’ve learned that a chemical refrigerator or a low-humidity storage cabinet does more than create compliance; it keeps the compound from breaking down or forming new byproducts that nobody expected. Solid shelving, free from bumps, steadies bottles and helps prevent breaks. A locked cabinet not only keeps out curious hands—it also tells folks that chemicals inside deserve respect.
Plastic trays or bins catch leaks before they reach the floor. If a spill or slow leak happens, cleanup stays simple and the threat to people and property drops. In my experience, secondary containment often gets skipped until the first accident shows why it matters. Companies that invest a few dollars in good bins avoid headaches and injury later.
Good recordkeeping comes up every time something goes wrong. A notebook or spreadsheet tracking purchases, uses, and inspections gives everyone a snapshot of what’s really happening on the shelves. I trust labels printed with proper dates and hazard warnings. A safety data sheet stuck to the inside of the cabinet door is no substitute for real training, but it keeps vital facts close at hand in a crunch.
Trust builds when every staff member knows where the risk zones lie, from freshmen to seasoned chemists. Regular reviews of chemical handling, combined with reminders that nobody’s above double-checking their work, help a workplace tap into experience and caution. Friendly talk about storage mistakes—those near-misses everyone remembers—provides a chance for the entire team to learn without judgment.
Better storage for potassium antimonyl tartrate monohydrate protects people and experiments. It rewards anyone willing to adjust their habits and update protocols after close calls. Lab safety isn’t a one-time fix; it’s built on knowing the risks, choosing smart storage, and making sure everyone has a real say in keeping things safe.
Potassium Antimonyl Tartrate Monohydrate grabs attention not just because of its chemical formula, but because it hides some sharp risks behind that mouthful of a name. Folks use it in medical testing, textile dyeing, and lab settings. Toxicity isn’t some technicality here—exposure means real harm, especially if someone breathes it in or swallows it. Over years working with hazardous powders, experience tells me many folks ignore the basics until the health scare arrives. That’s not some remote possibility; antimony compounds have damaged organs, triggered chronic illnesses, and caused accidental poisonings in labs that skipped steps.
This isn’t just another white lab coat moment. Respirators matter. Antimony, the metal at the heart of this compound, delivers its punch through dust. Using a simple surgical mask falls short. Certified respiratory protection blocks that fine powder from sneaking into lungs. Goggles never feel convenient, but eye contact can burn or irritate. Contaminated gloves aren’t optional, either. I’ve seen hands turn red and blistered because of a hot second’s contact with chemicals like this. Chemical-resistant gloves, like nitrile or neoprene, stop a nasty surprise after the shift ends. Protective clothing, even if it feels like overkill, keeps that powder away from regular street attire, cutting down the risk of taking “work” home.
Only open containers inside a certified chemical fume hood. A strong fan or open window won’t cut it; only a hood with proper airflow keeps those invisible particles from hanging in the air or spreading to nearby surfaces. I’ve cleaned up enough spills in my time to know that preparedness beats panic. Keep spill kits nearby and don’t try sweeping or vacuuming dry powder—specialized vacuums made for hazardous dust are worth the investment.
Avoid eating, drinking, or even touching your phone when working with the compound. Hands become invisible transporters of contamination to mouth and face. Washing with soap and water after any exposure matters, as antimony compounds linger and sneak into cracks in dry skin. No amount of hand sanitizer substitutes for a proper scrub.
Keep this chemical tightly sealed and away from acids. Combined with acids, antimony-based compounds release toxic gases. Label all containers clearly, and use lockable cabinets away from easy-access areas. Over the years, I’ve seen more than one case where someone set a container down “for a few minutes,” only for a curious colleague or student to bump it later on. Secure storage stops accidents before they start.
Never pour leftover potassium antimonyl tartrate down a drain. Local regulations usually demand hazardous waste protocols, and for good reason. Antimony ends up in waterways, posing risks for animals and people. Partnerships with licensed chemical disposal companies offer an easy route, and they document the process in ways regulators want to see.
No set of rules replaces real experience. I learned from older, meticulous chemists who reviewed safety data sheets with me, reminded me why protocols exist, and shared the long-term harm witnessed from cutting corners. Training new staff—hands-on, with real PPE and walkthroughs—turns abstract danger into daily routine. That attitude, more than any checklist, creates labs where accidents lose their chance to begin.
| Names | |
| Preferred IUPAC name | dipotassium 2,3-dihydroxybutanedioate; antimony(3+); monohydrate |
| Other names |
Tartar Emetic Antimony Potassium Tartrate Potassium Antimonate Tartrate Antimonyl Potassium Tartrate Potassium antimoniotartrate Tartarus emeticus Potassium antimonyl tartrate monohydrate Antimony potassium tartrate trihydrate |
| Pronunciation | /pəˈtæsiəm ænˈtɪməni̯ɪl tɑːrˈtreɪt ˌmɒnəˈhaɪdreɪt/ |
| Identifiers | |
| CAS Number | 28300-74-5 |
| Beilstein Reference | 107497 |
| ChEBI | CHEBI:131378 |
| ChEMBL | CHEMBL1200942 |
| ChemSpider | 12641618 |
| DrugBank | DB14544 |
| ECHA InfoCard | 100.015.164 |
| EC Number | 206-089-5 |
| Gmelin Reference | 82898 |
| KEGG | D03175 |
| MeSH | D010899 |
| PubChem CID | 24853146 |
| RTECS number | WM8575000 |
| UNII | 4Z5F84HA6Y |
| UN number | UN #1332 |
| Properties | |
| Chemical formula | K2Sb2(C4H2O6)2·H2O |
| Molar mass | 667.87 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 2.6 g/cm³ |
| Solubility in water | soluble |
| log P | -3.3 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 2.68 |
| Basicity (pKb) | 4.2 |
| Magnetic susceptibility (χ) | -72.0e-6 cm³/mol |
| Dipole moment | 0 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 253 J K⁻¹ mol⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -2060.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3734 kJ/mol |
| Pharmacology | |
| ATC code | S01XA12 |
| Hazards | |
| Main hazards | Toxic if swallowed. May cause cancer by inhalation. Causes serious eye irritation. |
| GHS labelling | GHS05, GHS06, GHS08 |
| Pictograms | GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H302, H373 |
| Precautionary statements | P264, P270, P301+P312, P302+P352, P305+P351+P338, P308+P313, P330, P501 |
| NFPA 704 (fire diamond) | 2-2-2-W |
| Lethal dose or concentration | LD50 Oral Rat 115 mg/kg |
| LD50 (median dose) | 115 mg/kg (oral, rat) |
| NIOSH | SN1650000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Potassium Antimonyl Tartrate Monohydrate: "0.5 mg/m3 (as Sb) |
| REL (Recommended) | 0.5 mg Sb/m³ |
| Related compounds | |
| Related compounds |
Antimony Potassium Tartrate Potassium Tartrate Antimony Tartrate Sodium Antimonyl Tartrate |
